Literature DB >> 30735241

Pathology of white matter integrity in three major white matter fasciculi: A post-mortem study of schizophrenia and treatment status.

Kirsten E Schoonover1, Charlene B Farmer2, Andrew E Cash2, Rosalinda C Roberts2.   

Abstract

BACKGROUND AND
PURPOSE: Imaging studies have shown that people with schizophrenia exhibit abnormal connectivity termed "dysconnectivity" in several white matter tracts, including the cingulum bundle (CB), corpus callosum (CC), and arcuate fasciculus (AF). This study aimed to elucidate potential contributors to schizophrenia "dysconnectivity." EXPERIMENTAL APPROACH: Western blot analysis was used to compare protein levels of myelin basic protein, neurofilament heavy, autophagosome marker LC3, and microtubule marker α-tubulin in post-mortem human CB, CC, and AF in schizophrenia subjects (SZ) and matched normal controls (NC). Additionally, SZ cases were subdivided by treatment status: off-medication (OFF) or on-medication (ON). KEY
RESULTS: In the CC, the combined SZ group exhibited less neurofilament heavy protein than the NCs. In the CB, the combined SZ group had similar levels of α-tubulin protein versus NC, but OFF subjects had increased α-tubulin protein versus ON and NCs. There were significant correlations between α-tubulin and all other proteins but only in the CB. The strong negative relationship between α-tubulin versus myelin basic protein and α-tubulin versus LC3 in NCs was absent in SZs; coefficients comparison showed significant differences. Preliminary race analyses revealed that African American SZ had less AF α-tubulin than Caucasian SZ and African American normal controls. CONCLUSIONS AND IMPLICATIONS: The results show a relationship between tract- and protein-specific abnormalities and diagnosis, treatment, and race. These data suggest there is a dysregulation of the relationship between α-tubulin and the other markers of white matter integrity observed in the CB in schizophrenia.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30735241      PMCID: PMC6451068          DOI: 10.1111/bph.14612

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  62 in total

1.  Alterations of white matter connectivity in first episode schizophrenia.

Authors:  Andrea Federspiel; Stefan Begré; Claus Kiefer; Gerhard Schroth; Werner K Strik; Thomas Dierks
Journal:  Neurobiol Dis       Date:  2006-04-19       Impact factor: 5.996

2.  Chronic cigarette smoking and the microstructural integrity of white matter in healthy adults: a diffusion tensor imaging study.

Authors:  Robert H Paul; Stuart M Grieve; Raymond Niaura; Sean P David; David H Laidlaw; Ronald Cohen; Lawrence Sweet; George Taylor; Richard C Clark; Sakire Pogun; Evian Gordon
Journal:  Nicotine Tob Res       Date:  2008-01       Impact factor: 4.244

3.  Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response.

Authors:  K A Barksdale; A C Lahti; Rosalinda C Roberts
Journal:  Neuropsychopharmacology       Date:  2014-03-07       Impact factor: 7.853

4.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

5.  The disconnection hypothesis.

Authors:  K J Friston
Journal:  Schizophr Res       Date:  1998-03-10       Impact factor: 4.939

Review 6.  NAP (davunetide) provides functional and structural neuroprotection.

Authors:  Illana Gozes
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 7.  Diffusion tensor imaging in schizophrenia.

Authors:  Marinos Kyriakopoulos; Theodoros Bargiotas; Gareth J Barker; Sophia Frangou
Journal:  Eur Psychiatry       Date:  2008-06-04       Impact factor: 5.361

8.  Tractography Analysis of 5 White Matter Bundles and Their Clinical and Cognitive Correlates in Early-Course Schizophrenia.

Authors:  Johanna Seitz; Jessica X Zuo; Amanda E Lyall; Nikos Makris; Zora Kikinis; Sylvain Bouix; Ofer Pasternak; Eli Fredman; Jonathan Duskin; Jill M Goldstein; Tracey L Petryshen; Raquelle I Mesholam-Gately; Joanne Wojcik; Robert W McCarley; Larry J Seidman; Martha E Shenton; Inga K Koerte; Marek Kubicki
Journal:  Schizophr Bull       Date:  2016-03-23       Impact factor: 9.306

9.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  Variability of 128 schizophrenia-associated gene variants across distinct ethnic populations.

Authors:  K Ohi; T Shimada; T Yasuyama; T Uehara; Y Kawasaki
Journal:  Transl Psychiatry       Date:  2017-01-03       Impact factor: 6.222

View more
  4 in total

1.  Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice.

Authors:  Kirsten E Schoonover; Laura J McMeekin; Charlene B Farmer; Neelu E Varghese; Stacy L Queern; Suzanne E Lapi; Rita M Cowell; Rosalinda C Roberts
Journal:  Brain Res Bull       Date:  2020-08-12       Impact factor: 4.077

2.  Markers of copper transport in the cingulum bundle in schizophrenia.

Authors:  Kirsten E Schoonover; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2021-01-09       Impact factor: 4.939

3.  Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.

Authors:  Kirsten E Schoonover; Charlene B Farmer; Charity J Morgan; Vidushi Sinha; Laura Odom; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2021-01-09       Impact factor: 4.939

4.  Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia.

Authors:  Inés Ibarra-Lecue; Rebeca Diez-Alarcia; Benito Morentin; J Javier Meana; Luis F Callado; Leyre Urigüen
Journal:  Front Pharmacol       Date:  2020-03-24       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.